Monday, May 19, 2025 10:59:04 AM
1.53 News good but offering cash short in future might let it run a little to trap longs.. NurOwn® data selected as Breakthrough Science for Presentation at ISCT 2025 MeetingThe new pharmacogenomic were delivered in a oral presentation at the International Society for Cell & Gene Therapy (ISCT) 2025 Annual Meeting, in New Orleans. The data highlight the impact of the UNC13A genotype on clinical outcomes for ALS patients treated with NurOwn. The presentation was featured in the ISCT public announcement regarding the meeting, which indicated that the data were "carefully reviewed and selected by the ISCT 2025 Planning Faculty, to explore the latest breakthroughs in the clinical translation of Mesenchymal Stem/Stromal Cells and how they will shape the future of cell therapies."...
Recent BCLI News
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 10/09/2025 07:20:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2025 09:03:10 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 07/03/2025 08:31:22 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 06/25/2025 08:39:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/25/2025 08:31:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/16/2025 08:30:51 PM
- Micro-Cap Biotech Spikes After Revealing Strong ALS Survival Outcomes • AllPennyStocks.com • 06/16/2025 05:27:00 PM
- Micro Cap Bid Up Aggressively On FDA Clearance Announcement • AllPennyStocks.com • 05/19/2025 01:50:00 PM
- Nasdaq Top 5 Premarket Gainers • IH Market News • 05/19/2025 01:07:08 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/06/2025 08:30:33 PM
